Pomalidomide, sold under the brand names Pomalyst and Imnovid, is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. From Wikipedia
The pharmaceutical company forecasts lower-than-expected earnings and revenue as it faces generic competition for key cancer drugs.
